One of the public health concerns about prescription opioids, including for pain, is diversion, but injectables can help avoid those concerns. Last spring Hikma released a new generic buprenorphine injectable product indicated for pain, a generic version of Indivior’s Buprenex.
For more information, go to https://www.hikma.com/newsroom/article-i4808-hikma-launches-buprenorphine-hydrochloride-injection/